Benefits of omalizumab on anxiety and depression in patients with severe asthma

Background: Asthma is one of the most common chronic diseases and may cause psychiatric disorders affecting the patients’ quality of life. In our study, we evaluated the effect of omalizumab treatment on anxiety disorder and depression using Beck Depression Scale (BDS) and State Trait Anxi...

Full description

Bibliographic Details
Main Authors: Fatih Uzer, Omer Ozbudak
Format: Article
Language:English
Published: Babol University of Medical Sciences 2018-05-01
Series:Caspian Journal of Internal Medicine
Subjects:
Online Access:http://caspjim.com/browse.php?a_code=A-10-881-2&slc_lang=en&sid=1